Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection-Reference-Cited by-同舟云学术

Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection

Published:2014-01-28 Issue:3 Volume:28 Page:325-334
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Puertas Maria C.,Massanella Marta,Llibre Josep M.,Ballestero Monica,Buzon Maria J.,Ouchi Dan,Esteve Anna,Boix Jaume,Manzardo Christian,Miró Josep M.,Gatell Josep M.,Clotet Bonaventura,Blanco Julià,Martinez-Picado Javier

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference39 articles.

1. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.;Palmer;Proc Natl Acad Sci U S A,2008

2. The challenge of finding a cure for HIV infection.;Richman;Science,2009

3. HIV infection, inflammation, immunosenescence, and aging.;Deeks;Annu Rev Med,2011

4. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.;Chun;AIDS,2012

5. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.;Else;Antivir Ther,2011

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-level viremia in HIV infection: causes and consequences;HIV Infection and Immunosuppressive Disorders;2024-09-05

2. Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses;European Journal of Medicinal Chemistry;2024-02

3. Eliminating the HIV tissue reservoir: current strategies and challenges;Infectious Diseases;2023-12-27

4. Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure;Current HIV/AIDS Reports;2023-11-13

5. Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial;Journal of Antimicrobial Chemotherapy;2022-06-28